Vanberra Signal

Endoart

Curated by Signal

Developer of remote controlled implant for treatment of obesity

Overview

EndoArt is developing remote-controlled medical devices. The has developed a technology platform, FloWatch technology, which assist its EASYBAND, a remotely adjustable gastric band system (an implant), a telemetrically-adjustable gastric banding device for the treatment of morbid obesity. The band system is surgically implanted around the upper stomach which monitors the obesity treatment. It is approved by the EU. The company is acquired by Allergan in Feb 2007.

Key facts

Founded
1998

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Ethereum-based DNA analytics solution

    Life Sciences TechnologyBasel, Switzerland
  • Developer of AI and mass spectrometry-based platform for personalized medicine

    Life Sciences TechnologyRisch Rotkreuz, Switzerland
  • Developer of medical imaging equipment for the diagnosis of cachexia

    Life Sciences TechnologyGeneva, Switzerland

About Endoart

What does Endoart do?

EndoArt is developing remote-controlled medical devices.

Where is Endoart headquartered?

Endoart is headquartered in Lausanne, Switzerland.

When was Endoart founded?

Endoart was founded in 1998.

Which sector is Endoart in?

Endoart operates in Life Sciences Technology.

Who are Endoart's competitors?

Companies similar to Endoart include Helixstreet, Deep Breath Intelligence, and Adiposs.